Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.60 |
| ▸ | SLC6A5 | Q9Y345 | 3/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16553079 | 1.00 | CNR1 (0.60) | CNR1SLC6A5EPHX2KDM4EALDH1A1 | |
| SCHEMBL16552975 | 1.00 | CNR1 (0.60) | CNR1SLC6A5EPHX2KDM4EALDH1A1 | |
| SCHEMBL12667224 | 1.00 | CNR1 (0.60) | CNR1SLC6A5EPHX2KDM4EALDH1A1 | |
| SCHEMBL13561439 | 1.00 | CNR1 (0.60) | CNR1SLC6A5EPHX2KDM4EALDH1A1 | |
| SCHEMBL12667229 | 1.00 | CNR1 (0.60) | CNR1SLC6A5EPHX2KDM4EALDH1A1 | |
| SCHEMBL1866483 | 0.96 | SLC6A5 (0.64) | CNR1SLC6A5EPHX2 | |
| SCHEMBL12087758 | 0.96 | SLC6A5 (0.64) | CNR1SLC6A5EPHX2 | |
| SCHEMBL1866485 | 0.96 | SLC6A5 (0.64) | CNR1SLC6A5EPHX2 | |
| SCHEMBL12148896 | 0.96 | SLC6A5 (0.64) | CNR1SLC6A5EPHX2 | |
| SCHEMBL16553006 | 0.91 | SLC6A5 (0.60) | CNR1SLC6A5EPHX2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150073038-A1 | DELIVERY MOLECULES FOR THERAPEUTICS | MARINA BIOTECH INC (US) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150073038-A1 | DELIVERY MOLECULES FOR THERAPEUTICS | LNPEP, LDLR, XPA | CNR1 1874/4885SLC6A5 2329/4885EPHX2 2878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.